Zydus Lifesciences Q2 Net Profit Drops 26.6% to ₹925.5 Crore
Zydus Lifesciences reported a 26.6% decline in net profit to ₹925.5 crore for the September quarter. Revenue from operations rose 29.2% to ₹7,909.6 crore, while total expenses increased to ₹6,806.6 crore, affecting profitability. The pharmaceuticals segment accounted for 83% of sales, with India formulations generating ₹1,884.4 crore and North America formulations ₹3,314.5 crore, showing strong global performance.
ET Markets·



